| View |
2021-08-13-0431
|
HEPATITIS A VACCINE, INACTIVATED (GBM STRAIN)
|
AVAXIM 80
|
FDA-0297982
|
U3C27
|
Packaging Lot (Box): U3C274V; (PFS): U3C27
|
31 January 2023
|
16 August 2021
|
| View |
2022-03-23-0065
|
QUADRIVALENT SEASONAL INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED) 2022 SOUTHERN HEMISPHERE STRAIN
|
INFLUVAC TETRA
|
BR-1281
|
A17
|
Packaging Lot (Box & Pre-filled Syringe): A17
|
31 January 2023
|
25 March 2022
|
| View |
2022-03-30-0073
|
QUADRIVALENT SEASONAL INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED) 2022 SOUTHERN HEMISPHERE STRAIN
|
INFLUVAC TETRA
|
BR-1281
|
A19
|
Packaging Lot (Box & Pre-filed Syringe): A19
|
31 January 2023
|
31 March 2022
|
| View |
2022-04-06-0088
|
TRIVALENT INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)
|
INFLUVAC
|
BR-901
|
A20
|
Packaging Lot (Box & Vial): A20
|
31 January 2023
|
8 April 2022
|
| View |
2022-05-19-0122
|
DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)
|
TETRAXIM
|
BR-518
|
U3D60
|
Packaging Lot (Box): U3D603V; (Pre-filled Syringe): U3D60/U3D603V; (Needle 25G x 5/8''): 2009040; (Needle 23G x 1''): 2008010
|
31 January 2023
|
26 May 2022
|
| View |
2021-09-17-0474
|
PNEUMOCOCCAL CONJUGATE VACCINE 13- VALENT (ADSORBED)
|
PREVENAR 13
|
BR-1308
|
ET0604
|
Packaging Lot (Box & Vial): ET3670
|
31 January 2024
|
20 September 2021
|
| View |
2021-10-21-0504
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0161W015
|
Packaging Lot (Box & Vial): 0161W015; (Diluent): 0681S1070
|
31 January 2024
|
25 October 2021
|
| View |
2022-02-04-0030
|
INACTIVATED POLIOMYELITIS VACCINE (TYPE 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-929
|
V3C64
|
Packaging Lot (Box): V3C641V; (Vial): V3C64
|
31 January 2024
|
7 February 2022
|
| View |
2022-02-04-0031
|
INACTIVATED POLIOMYELITIS VACCINE (TYPE 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-929
|
V3C82
|
Packaging Lot (Box): V3C821V; (Vial): V3C82
|
31 January 2024
|
7 February 2022
|
| View |
2022-04-29-0102
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822005
|
Packaging Lot (Box & Vial): A06822005
|
31 January 2024
|
4 May 2022
|
| View |
2022-05-23-0123
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822006
|
Packaging Lot (Box & Vial): A06822006
|
31 January 2024
|
26 May 2022
|
| View |
2022-05-24-0125
|
HUMAN TETANUS IMMUNOGLOBULIN
|
TETAGAM P
|
BR-599
|
P100310254
|
Packaging Lot (Pre-filled Syringe): P100392457
|
31 January 2024
|
26 May 2022
|
| View |
2022-05-24-0126
|
HUMAN TETANUS IMMUNOGLOBULIN
|
TETAGAM P
|
BR-599
|
P100313076
|
Packaging Lot (Pre-filled Syringe): P100392459
|
31 January 2024
|
26 May 2022
|
| View |
2022-05-30-0131
|
TETANUS AND DIPTHTHERIA TOXOIDS ADSORBED COMBINED WITH COMPONENT ACELLULAR PERTUSSIS VACCINE
|
ADACEL
|
BR-613
|
C5968A
|
Packaging Lot (Box & Vial): C5968AB
|
31 January 2024
|
2 June 2022
|
| View |
2022-07-29-0206
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-574
|
0342Q005A
|
Packaging Lot (Box & Vial): 0342Q005A
|
31 January 2025
|
2 August 2022
|
| View |
2022-08-10-0218
|
PNEUMOCOCCAL CONJUGATE VACCINE, 13-VALENT (ADSORBED)
|
PREVENAR 13
|
BR-1133
|
FM6163
|
Packaging Lot (Box & Pre-filled Syringe): GA0077; (Needle 25G): 2202031
|
31 January 2025
|
16 August 2022
|
| View |
2018-11-16-0250
|
Hepatitis B Vaccine (rDNA)
|
Genvac B
|
BR-567
|
0328Y026CE
|
Packaging Lot: Box & vial - 0328Y026CE
|
31 July 2021
|
20 November 2018
|
| View |
2018-11-27-0268
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
BR-326
|
2598I001A
|
Packaging lot (box and ampoule): 2598I001A
|
31 July 2021
|
29 November 2018
|
| View |
2019-02-01-0020
|
Inactivated Hepatitis A Vaccine
|
Havrix 720
|
BR-376
|
AHAVB990A
|
Packaging Lot: Box & Vial - AHAVB990AB
|
31 July 2021
|
06 February 2019
|
| View |
2019-07-25-0172
|
Diphtheria-Tetanus Toxoids and Acellular Pertussis Vaccine
|
Boostrix
|
BR-630
|
AC37B335C
|
Packaging Lot: Box and PFS - AC37B335CF; Needle (23G x 1") - 1811022 (ED: 2023-10-31); Needle (25G x 5/8") - 1810014 (ED: 2023-09-30)
|
31 July 2021
|
26 July 2019
|